Objectives We have investigated the molecular epidemiology and distribution of
carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii …

In total, 96 carbapenem-resistant isolates of Acinetobacter baumannii were obtained from 25
hospitals in 17 European countries. Imipenem MICs ranged from< 4 to 128 mg/L on retesting …

Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing
relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) …

Genotypes of carbapenem-resistant Acinetobacter baumannii collected by the clinical
microbiology laboratory of a university hospital in Chicago, IL, between 2004 and 2007 were …

Objectives: To investigate the resistance mechanisms and the genetic relationship of
imipenem-resistant Acinetobacter baumannii isolates recovered in the intensive care unit …

Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat
in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in …

During 2005 we detected a multicity outbreak of infections or colonization due to high-level
imipenem-resistant Acinetobacter baumannii (MIC, 64 μg/ml). One hundred isolates from …

Objective To compare the incidence of carbapenemase genes in Acinetobacter baumannii
between two time periods. Methods We studied 114 isolates of imipenem-resistant A …

Objectives We investigated the molecular epidemiology of carbapenem-resistant
Acinetobacter baumannii from a Taiwanese hospital and determined the mechanisms …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …